GleamWall
中文EN

CODX Co-Diagnostics, Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1692415 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY69.1%
TTM net income YoY-47.5%
TTM EPS YoY60.1%
Revenue 3-yr CAGR-43.1%
Net income 3-yr CAGR—

Margins

Gross margin20.3%
Operating margin-5,614.3%
Net margin-5,527.6%
FCF margin-3,165.7%
EBITDA margin-5,504.0%

Returns

ROE-194.5%
ROA-165.0%
ROIC (approx.)-207.8%
Asset turnover0.03x

Leverage & solvency

Liabilities / assets26.3%
Debt / equity0.00x
Current ratio0.77x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.57x
Accruals ratio-71.6%
Payout ratio—
Capex / revenue35.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$282,881$166,131$145,954$263,922$145,380$162,910$50,277$149,325
Cost of revenue$303,344$45,303$193,768$142,396$26,285$32,106$21,590$255,068
Gross profit-$20,463$120,828-$47,814$121,526$119,095$130,804$28,687-$105,743
R&D expense$3.57M$4.15M$5.93M$5.10M$4.48M$4.69M$4.87M$4.81M
SG&A expense$1.87M$1.50M$2.50M$1.87M$1.82M$2.60M$2.77M$5.82M
Operating income-$6.27M-$6.20M-$9.21M-$26.54M-$7.01M-$8.06M-$8.55M-$11.91M
Pretax income-$6.31M-$6.26M-$9.14M-$26.22M-$7.05M-$7.72M-$7.52M-$11.04M
Income tax$500$19,168$520-$473,716-$1.17M$12,327$12,004-$8,175
Net income-$6.31M-$6.28M-$9.14M-$25.75M-$5.89M-$7.73M-$7.53M-$11.03M
EBITDA-$6.05M-$6.00M-$8.95M-$26.27M-$6.75M-$7.77M-$8.27M-$11.55M
EPS (basic)-1.01-1.46-4.06—-4.66-7.00-7.05—
EPS (diluted)-1.01-1.46-4.06—-4.66-7.00-7.05—
Weighted avg. shares (diluted)6.27M4.31M2.25M—1.26M1.10M1.07M—
Balance sheet
Cash & equivalents$714,803$3.65M$8.23M$11.88M$11.44M$11.12M$1.90M$2.94M
Short-term investments—————$2.25M$19.58M$26.81M
Receivables$51,828$52,059$82,339$190,375$55,905$210,968$136,391$132,570
Inventory$672,950$841,669$846,119$992,397$1.09M$1.08M$1.08M$1.07M
Current assets$1.94M$5.19M$9.78M$13.69M$14.05M$15.31M$23.83M$32.29M
PP&E, net$1.77M$1.98M$2.16M$2.27M$2.49M$2.67M$2.59M$2.76M
Intangibles$7.22M$7.22M$7.22M$7.22M$26.10M$26.10M$26.10M$26.10M
Total assets$12.79M$16.59M$21.50M$24.74M$44.74M$46.47M$55.15M$63.56M
Current liabilities$2.51M$2.86M$4.28M$3.54M$3.69M$3.71M$5.38M$7.32M
Total liabilities$3.37M$3.88M$5.46M$4.11M$4.91M$5.33M$7.23M$9.69M
Shareholders' equity$9.43M$12.71M$16.04M$20.63M$39.39M$40.70M$47.48M$53.88M
Shares outstanding7.29M4.88M3.60M2.10M48.14M36.18M33.57M1.10M
Cash flow statement
Operating cash flow-$5.68M-$7.15M-$7.85M-$6.20M-$5.90M-$8.29M-$8.75M-$8.23M
Capital expenditure$15,001$18,281$142,017$131,969$75,105$401,060$91,913$72,987
Free cash flow-$5.70M-$7.17M-$7.99M-$6.33M-$5.98M-$8.69M-$8.84M-$8.30M
Investing cash flow-$15,001-$168,281-$142,017-$329,423$2.17M$17.07M$7.36M$266,006
Financing cash flow$2.76M$2.74M$4.33M$6.97M$4.06M$429,000$354,746—
Depreciation & amortization$222,363$201,840$255,445$267,566$267,383$291,414$280,445$357,123
Stock-based compensation$255,184$213,752$219,114$291,975$500,585$580,265$875,228$1.32M

Free plan shows the latest 8 periods; Pro shows all 42 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.